New Mexico Educational Retirement Board decreased American Airlines Group Inc (AAL) stake by 15.5% reported in 2017Q3 SEC filing. New Mexico Educational Retirement Board sold 7,100 shares as American Airlines Group Inc (AAL)’s stock declined 3.60%. The New Mexico Educational Retirement Board holds 38,700 shares with $1.84 million value, down from 45,800 last quarter. American Airlines Group Inc now has $24.90B valuation. The stock decreased 0.82% or $0.43 during the last trading session, reaching $52.03. About 2.70 million shares traded. American Airlines Group Inc. (NASDAQ:AAL) has risen 40.65% since January 1, 2017 and is uptrending. It has outperformed by 23.95% the S&P500.
Atara Biotherapeutics Incorporated (NASDAQ:ATRA) had an increase of 0.5% in short interest. ATRA’s SI was 5.06 million shares in January as released by FINRA. Its up 0.5% from 5.04M shares previously. With 112,800 avg volume, 45 days are for Atara Biotherapeutics Incorporated (NASDAQ:ATRA)’s short sellers to cover ATRA’s short positions. The SI to Atara Biotherapeutics Incorporated’s float is 47.13%. The stock increased 18.69% or $2.85 during the last trading session, reaching $18.1. About 5.81M shares traded or 2028.56% up from the average. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has declined 7.28% since January 1, 2017 and is downtrending. It has underperformed by 23.98% the S&P500.
Investors sentiment increased to 1.54 in 2017 Q3. Its up 0.26, from 1.28 in 2017Q2. It increased, as 8 investors sold Atara Biotherapeutics, Inc. shares while 16 reduced holdings. 9 funds opened positions while 28 raised stakes. 26.16 million shares or 3.51% more from 25.27 million shares in 2017Q2 were reported. Vanguard Group Inc has 918,150 shares. Morgan Stanley has invested 0.01% in Atara Biotherapeutics, Inc. (NASDAQ:ATRA). Proshare Limited Liability Corp stated it has 0% in Atara Biotherapeutics, Inc. (NASDAQ:ATRA). Deutsche Natl Bank Ag holds 25,520 shares. Ameritas Inv reported 0% of its portfolio in Atara Biotherapeutics, Inc. (NASDAQ:ATRA). Tiaa Cref Mngmt Ltd Liability Co has invested 0% in Atara Biotherapeutics, Inc. (NASDAQ:ATRA). Wells Fargo Mn has invested 0% in Atara Biotherapeutics, Inc. (NASDAQ:ATRA). Essex Investment Management Lc accumulated 25,905 shares. Great West Life Assurance Communications Can holds 1,654 shares. Raymond James & Associates owns 23,606 shares. 9,200 are owned by Dekabank Deutsche Girozentrale. Northern holds 0% of its portfolio in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) for 286,973 shares. 12 West Capital Mgmt L P holds 398,700 shares. Prelude Capital Mngmt Limited Liability Corporation holds 0.02% of its portfolio in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) for 13,225 shares. 431,050 are owned by State Street.
Since August 10, 2017, it had 0 buys, and 14 selling transactions for $999,963 activity. The insider MCGRATH JOHN sold 4,200 shares worth $60,102. Another trade for 4,400 shares valued at $59,774 was made by Ciechanover Isaac E. on Thursday, October 26. The insider Soffer Gad sold 9,464 shares worth $140,802. Haqq Christopher sold 6,000 shares worth $91,800. On Tuesday, August 15 Gallagher Carol Giltner sold $16,931 worth of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) or 1,184 shares. Clark Mitchall G. had sold 3,021 shares worth $43,291.
Among 6 analysts covering Atara Biotherapeutics (NASDAQ:ATRA), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. Atara Biotherapeutics had 17 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) earned “Buy” rating by Jefferies on Thursday, June 22. As per Thursday, September 15, the company rating was downgraded by Goldman Sachs. As per Friday, October 9, the company rating was initiated by William Blair. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has “Sell” rating given on Tuesday, December 15 by Citigroup. The firm has “Sell” rating by Citigroup given on Monday, August 22. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has “Market Outperform” rating given on Tuesday, December 15 by JMP Securities. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) earned “Buy” rating by Jefferies on Monday, October 24. The firm has “Buy” rating given on Wednesday, September 9 by Canaccord Genuity. The firm has “Market Outperform” rating by JMP Securities given on Wednesday, March 9. The rating was maintained by Jefferies on Thursday, August 31 with “Buy”.
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with severe and life-threatening diseases in the United States. The company has market cap of $553.79 million. The Company’s clinical stage T-cell product candidates include ATA129 that focuses on Phase III clinical trials for the treatment of rituximab-refractory epstein-barr virus associated post-transplant lymphoproliferative disorder after hematopoietic cell transplant and solid organ transplant; ATA188, which is in Phase I clinical trial for the treatment of multiple sclerosis; ATA520, a Phase I clinical trial product targeting cancers expressing the antigen Wilms tumor 1; and ATA230, which is Phase III clinical trials for refractory cytomegalovirus. It currently has negative earnings. The firm is also developing a next generation of allogeneic T-cell product candidates utilizing a technology to selectively enhance a T-cellÂ’s ability to target specific viral proteins implicated in disease.
Investors sentiment decreased to 0.66 in Q3 2017. Its down 0.25, from 0.91 in 2017Q2. It turned negative, as 53 investors sold AAL shares while 210 reduced holdings. 55 funds opened positions while 118 raised stakes. 380.49 million shares or 2.17% less from 388.91 million shares in 2017Q2 were reported. Da Davidson accumulated 13,111 shares. Exxonmobil Invest Mngmt Tx stated it has 0.1% in American Airlines Group Inc. (NASDAQ:AAL). Sei Invs stated it has 360,754 shares or 0.06% of all its holdings. Century Inc invested in 0.05% or 989,718 shares. Brinker reported 16,214 shares. Prudential Financial Inc reported 931,450 shares. Gateway Advisers Lc has invested 0.16% in American Airlines Group Inc. (NASDAQ:AAL). Wellington Shields Ltd Liability Com has invested 0.19% in American Airlines Group Inc. (NASDAQ:AAL). State Of Alaska Department Of Revenue owns 19,970 shares. Palo Cap stated it has 14,377 shares or 0.36% of all its holdings. Fjarde Ap stated it has 0% of its portfolio in American Airlines Group Inc. (NASDAQ:AAL). Glg Ptnrs LP accumulated 6,722 shares. Dnb Asset Mngmt As owns 0.01% invested in American Airlines Group Inc. (NASDAQ:AAL) for 10,300 shares. Glenmede Trust Na holds 62,331 shares or 0.01% of its portfolio. The New York-based Omega has invested 0.33% in American Airlines Group Inc. (NASDAQ:AAL).
Analysts await American Airlines Group Inc. (NASDAQ:AAL) to report earnings on January, 26. They expect $0.71 EPS, down 22.83% or $0.21 from last year’s $0.92 per share. AAL’s profit will be $339.73 million for 18.32 P/E if the $0.71 EPS becomes a reality. After $1.42 actual EPS reported by American Airlines Group Inc. for the previous quarter, Wall Street now forecasts -50.00% negative EPS growth.
Among 23 analysts covering American Airlines Group (NASDAQ:AAL), 11 have Buy rating, 4 Sell and 8 Hold. Therefore 48% are positive. American Airlines Group had 66 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Monday, October 23 with “Buy”. The stock has “Overweight” rating by Morgan Stanley on Thursday, April 28. The stock of American Airlines Group Inc. (NASDAQ:AAL) has “Neutral” rating given on Friday, September 15 by JP Morgan. The stock of American Airlines Group Inc. (NASDAQ:AAL) has “Equal-Weight” rating given on Wednesday, March 22 by Morgan Stanley. The rating was initiated by Imperial Capital with “In-Line” on Friday, August 26. As per Friday, October 21, the company rating was maintained by Wolfe Research. The firm has “Strong-Buy” rating by Vetr given on Thursday, August 27. The firm has “Outperform” rating given on Thursday, January 7 by Credit Suisse. The company was downgraded on Wednesday, July 6 by Credit Suisse. Citigroup maintained American Airlines Group Inc. (NASDAQ:AAL) rating on Thursday, July 13. Citigroup has “Buy” rating and $67 target.
The post New Mexico Educational Retirement Board Trimmed By $333,700 Its American Airlines Group (AAL) Stake; Shorts at Atara Biotherapeutics (ATRA) Raised By 0.5% appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/01/01/new-mexico-educational-retirement-board-trimmed-by-333700-its-american-airlines-group-aal-stake-shorts-at-atara-biotherapeutics-atra-raised-by-0-5/
No comments:
Post a Comment